Embla Medical hf. (OSSUY) Q3 2026 Earnings Call Transcript
(OSSUY) Q3 2026 Earnings Call October 20, 2026 3:00 AM EDT Sveinn Sölvason - President & CEOGudny Sveinsdottir - Chief Financial Officer Martin Brenoe - Nordea Markets, Research DivisionTobias Nissen - Danske Bank A/S, Research DivisionBeatrice Fairbairn - Joh.
KG, Research DivisionTom RosenfeldYiwei Zhou - SEB, Research Division At this time, I would like to welcome everyone to this Embla Medical Q3 2026 Conference Call.
[Operator Instructions] Today's call is being recorded.
If you have any objections, please disconnect at this time.
I would now like to introduce President and CEO, Sveinn Solvason; and CFO, Arna Sveinsdottir.
Thank you very much, and good morning, everyone, and welcome to Embla Medical's Third Quarter 2026 Conference Call.
I'm Sveinn Solvason, President and CEO of Embla Medical.
And joining me today are our Chief Financial Officer, Arna Sveinsdottir; and our Head of Investor Relations, Klaus Sindahl.
We expect the presentation to take around 15 minutes, and we will then open the call for questions.
For the first 9 months, sales reached $741 million with reported growth of 10% and organic growth of 5%.
Growth in the quarter was led by Prosthetics & Neuro Orthotics, while bracing and supports delivered moderate growth.
Patient Care was flat in the quarter and performance is below our expectations that we set at the start of the year.
| Product | Price | Change |
|---|---|---|
| Brent Crude | $102.14/bbl | +0.34% |
| WTI Crude | $96.90/bbl | +0.21% |
| EN590 Diesel | $846/MT | +0.18% |
| Jet Fuel A-1 | $1090/MT | +0.55% |
| Mazut M100 | $450/MT | -0.15% |
| Bitumen 60/70 | $470/MT | +0.08% |
| Sulphur Gran 99.5% | $470/MT | -0.44% |
| Urea 46% Gran | $650/MT | +1.12% |
| NPK 16-16-16 | $460/MT | -0.28% |
| Nat Gas TTF | $15.42/MMBtu | +0.92% |
Comments
Post a Comment